Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.96 is in line with its 5-year average of 0.94, around the middle of its 5-year range (0.70–1.22).
As of the fiscal period ended Tuesday, June 30, 2026. 12.38% above its 12-month average of 0.86.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.96.
QUICK RATIO (ACID-TEST)
0.96
QUICK RATIO (ACID-TEST) AVG TTM
0.86
QUICK RATIO (ACID-TEST) AVG 3Y
0.99
QUICK RATIO (ACID-TEST) AVG 5Y
0.94
QUICK RATIO (ACID-TEST) AVG 10Y
0.86
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.38%
CURRENT VS 3Y AVG
-2.55%
CURRENT VS 5Y AVG
+2.95%
CURRENT VS 10Y AVG
+12.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.21
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
-20.26%
vs the sector median at left
Market Cap
$21.00B
Quick Ratio (Acid-Test)
5.41
TTM Avg
5.66
3Y Avg
6.29
5Y Avg
6.48
Market Cap
$18.45B
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.04
3Y Avg
0.96
5Y Avg
0.94
Market Cap
$17.09B
Quick Ratio (Acid-Test)
0.73
TTM Avg
0.83
3Y Avg
0.68
5Y Avg
0.84
Market Cap
$15.38B
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.86
3Y Avg
0.93
5Y Avg
0.94
Market Cap
$14.67B
Quick Ratio (Acid-Test)
3.38
TTM Avg
3.54
3Y Avg
3.46
5Y Avg
4.12
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $19.74B | 0.96 | 0.86 | 0.99 | 0.94 |
| STERIS plc (STE)vs › | $19.98B | 1.35 | 1.46 | 1.73 | 1.65 |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 5.41 | 5.66 | 6.29 | 6.48 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.45B | 1.69 | 1.04 | 0.96 | 0.94 |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 0.73 | 0.83 | 0.68 | 0.84 |
| Revvity, Inc. (RVTY)vs › | $16.00B | 1.50 | 2.21 | 2.02 | 1.79 |
| Solventum Corporation (SOLV)vs › | $15.38B | 0.74 | 0.86 | 0.93 | 0.94 |
| BioNTech SE (BNTX)vs › | $24.13B | 7.80 | 7.42 | 7.84 | 6.36 |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 3.38 | 3.54 | 3.46 | 4.12 |
| Incyte Corporation (INCY)vs › | $25.40B | 4.58 | 2.59 | 3.09 | 3.29 |
Quick Ratio
0.96
Excludes inventory
Current Ratio
1.58
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.96 |
| 2026-03-31 | 1.03 |
| 2025-12-31 | 0.74 |
| 2025-09-30 | 0.79 |
| 2025-06-30 | 0.77 |
| 2025-03-31 | 0.97 |
| 2024-12-31 | 0.98 |
| 2024-09-30 | 0.96 |
| 2024-06-30 | 1.02 |
| 2024-03-31 | 1.17 |
| 2023-12-31 | 1.22 |
| 2023-09-30 | 1.06 |
| 2023-06-30 | 0.94 |
| 2023-03-31 | 0.98 |
| 2022-12-31 | 1.05 |
| 2022-09-30 | 1.09 |
| 2022-06-30 | 0.98 |
| 2022-03-31 | 0.82 |
| 2021-12-31 | 0.70 |
| 2021-09-30 | 0.72 |
| 2021-06-30 | 0.72 |
| 2021-03-31 | 0.74 |
| 2020-12-31 | 0.70 |
| 2020-09-27 | 0.59 |
| 2020-06-28 | 0.53 |
| 2020-03-29 | 0.76 |
| 2019-12-31 | 0.73 |
| 2019-09-29 | 0.84 |
| 2019-06-29 | 0.77 |
| 2019-03-30 | 0.85 |
| 2018-12-30 | 0.83 |
| 2018-09-29 | 0.77 |
| 2018-06-29 | 0.77 |
| 2018-03-30 | 0.65 |
| 2017-12-30 | 0.73 |
| 2017-09-29 | 0.95 |
| 2017-06-29 | 0.84 |
| 2017-03-30 | 1.00 |
| 2016-12-30 | 1.01 |
| 2016-09-29 | 0.55 |
| 2016-06-29 | 2.65 |
| 2016-03-30 | 1.13 |
| 2015-12-30 | 1.10 |
| 2015-09-29 | 1.23 |
| 2015-06-29 | 1.11 |
| 2015-03-30 | 1.04 |
| 2014-12-30 | 0.90 |
| 2014-09-29 | 0.92 |
| 2014-06-29 | 1.03 |
| 2014-03-30 | 0.98 |
| 2013-12-30 | 0.95 |
| 2013-09-29 | 1.05 |
